A detailed history of Cerity Partners LLC transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 40,460 shares of MEDP stock, worth $16.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
40,460
Previous 2,463 1542.71%
Holding current value
$16.3 Million
Previous $754,000 2068.57%
% of portfolio
0.04%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$284.87 - $413.31 $10.8 Million - $15.7 Million
37,997 Added 1542.71%
40,460 $16.4 Million
Q4 2023

Jan 26, 2024

BUY
$227.52 - $312.68 $43,001 - $59,096
189 Added 8.31%
2,463 $754,000
Q3 2023

Nov 13, 2023

BUY
$233.98 - $281.67 $532,070 - $640,517
2,274 New
2,274 $550,000
Q1 2023

May 11, 2023

SELL
$174.31 - $239.52 $39,568 - $54,371
-227 Reduced 10.46%
1,944 $365,000
Q4 2022

Feb 15, 2023

BUY
$153.06 - $226.57 $332,293 - $491,883
2,171 New
2,171 $461,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.